These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 19482866

  • 21. Cladribine tablets' potential in multiple: sclerosis treatment.
    Costello K, Sipe JC.
    J Neurosci Nurs; 2008 Oct; 40(5):275-80. PubMed ID: 18856248
    [Abstract] [Full Text] [Related]

  • 22. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
    Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT, DEFINE Study Investigators.
    N Engl J Med; 2012 Sep 20; 367(12):1098-107. PubMed ID: 22992073
    [Abstract] [Full Text] [Related]

  • 23. Cladribine tablets: in relapsing-remitting multiple sclerosis.
    Muir VJ, Plosker GL.
    CNS Drugs; 2011 Mar 20; 25(3):239-49. PubMed ID: 21323395
    [Abstract] [Full Text] [Related]

  • 24. Effects of cladribine tablets on heart rate, atrio-ventricular conduction and cardiac repolarization in patients with relapsing multiple sclerosis.
    Hermann R, Litwin JS, Friberg LE, Dangond F, Munafo A.
    Br J Clin Pharmacol; 2019 Jul 20; 85(7):1484-1494. PubMed ID: 30883839
    [Abstract] [Full Text] [Related]

  • 25. Cladribine in aggressive forms of multiple sclerosis.
    Martinez-Rodriguez JE, Cadavid D, Wolansky LJ, Pliner L, Cook SD.
    Eur J Neurol; 2007 Jun 20; 14(6):686-9. PubMed ID: 17539951
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ.
    Clin Ther; 2006 Apr 20; 28(4):461-74. PubMed ID: 16750460
    [Abstract] [Full Text] [Related]

  • 32. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
    Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT, CONFIRM Study Investigators.
    N Engl J Med; 2012 Sep 20; 367(12):1087-97. PubMed ID: 22992072
    [Abstract] [Full Text] [Related]

  • 33. Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
    Polman C, Barkhof F, Sandberg-Wollheim M, Linde A, Nordle O, Nederman T, Laquinimod in Relapsing MS Study Group.
    Neurology; 2005 Mar 22; 64(6):987-91. PubMed ID: 15781813
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Safety and tolerability of subcutaneous cladribine therapy in progressive multiple sclerosis.
    Selby R, Brandwein J, O'Connor P.
    Can J Neurol Sci; 1998 Nov 22; 25(4):295-9. PubMed ID: 9827230
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
    Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, Ghazi-Visser L, Beelke M, SOLAR study group.
    J Neurol Sci; 2011 Dec 15; 311(1-2):44-9. PubMed ID: 21620416
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?
    Barkhof F, Hulst HE, Drulovic J, Uitdehaag BM, Matsuda K, Landin R, MN166-001 Investigators.
    Neurology; 2010 Mar 30; 74(13):1033-40. PubMed ID: 20200338
    [Abstract] [Full Text] [Related]

  • 40. Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosis.
    Sipe JC.
    Expert Rev Neurother; 2010 Mar 30; 10(3):365-75. PubMed ID: 20187859
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.